Loading provider…
Loading provider…
Pulmonary Disease Physician in Peoria, IL
NPI: 1366438087Primary Practice Location
Central Illinois Endoscopy Center
1001 Main St, Peoria, IL
Primary Employer
OSF Medical Group - Peoria
osfhealthcare.org
HQ Phone
Get M.D. Patrick's Phone Numberphone_androidMobile
Get M.D. Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 732 | 913 |
| 2 | 94729Measurement of lung diffusing capacity | 278 | 286 |
| 3 | 94726Determination of lung volumes using plethysmography | 277 | 285 |
| 4 | 94060Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | 259 | 269 |
| 5 | 94618Test for exercise-induced lung stress | 134 | 149 |
A randomised trial of lung sealant versus medical therapy for advanced emphysema.
Authors: Richard Mularski, Douglas Hogarth, Edmundo Rubio, Timothy Liesching, Mark Gotfried, Muhanned Abu-Hijleh, James Wells, Larry Tsai, Thomas Gildea, Carolyn Come, Roger Yusen, David Berkowitz, Nathaniel Marchetti, George Washko, Victor Pinto-Plata, Michael Pritchett, Christopher Cooper, Alexander Chen
Journal: Eur Respir J
Publication Date: 2015-04-02
Augmented Fluoroscopy: A New and Novel Navigation Platform for Peripheral Bronchoscopy.
Authors: Douglas Hogarth, Krishnendu Bhadra, Daniel Nader
Journal: J Bronchology Interv Pulmonol
Lead Sponsor: Gala Therapeutics, Inc.
Intervention / Treatment: DEVICE: Sham Procedure, DEVICE: RheOx Bronchial Rheoplasty
Lead Sponsor: Harmony Biosciences Management, Inc.
Intervention / Treatment: DRUG: Double-blind pitolisant, DRUG: Open-label pitolisant, DRUG: Double-blind placebo